PND69 Absence Benefit Utilization, Duration of Leaves, and Payments Vary By Benefit and over Time for Short- and Long-Term Disability and Workers' Compensation for Employees with Headaches and Migraines in the United States

2021 ◽  
Vol 24 ◽  
pp. S172
Author(s):  
R. Brook ◽  
N.L. Kleinman ◽  
I.A. Beren
Keyword(s):  
United States ◽  
The United States ◽  
Workers Compensation ◽  
Short And Long Term ◽  
Over Time

scholarly journals Rheumatoid Arthritis Disability and Absence Trends in the United States

2021 ◽  
Vol 2 (12) ◽  
pp. 1238-1245
Author(s):  
Richard A Brook ◽  
Nathan L Kleinman ◽  
Ian A Beren
Keyword(s):  
Rheumatoid Arthritis ◽  
United States ◽  
The United States ◽  
Database Analysis ◽  
Work Related ◽  
Constant Cost ◽  
Short And Long Term ◽  
Replacement Factor ◽  
Over Time

Objectives: Employers increasingly focus on absence benefits and connections with employee health. United States absence benefits include Sick Leave (SL), Short- and Long-Term Disability (STD and LTD, respectively) for non-work-related injuries/illnesses, and Workers’ Compensation (WC) for work-related injuries/illnesses. This research explores all-cause absence (SL, STD, LTD, and WC) utilization and changes from baseline for eligible employees with rheumatoid arthritis to determine if the use a constant payment factor is appropriate for models. Study Design: Retrospective multi-year database analysis. Methods: The Workpartners database (1/1/2001-12/31/2019) was used to identify employees with rheumatoid arthritis with adjudicated medical claims. Annual prevalence, benefit utilization, mean days of leave, and median payments (as % of salary) were analyzed. Annual outcomes were calculated as a percent of baseline (2001). Results: Rheumatoid arthritis prevalence averaged 0.5% between 2001 and 2019. At baseline, the percent of eligible employees using STD = 15.5%, LTD = 0.7%, WC = 1.7%, SL = 61.7%. Mean absence days were 48.5, 367.5, 43.8 for STD, LTD, WC, respectively and median payments were 70.5%, 22.2%, 65.7% of salary for STD, LTD, WC, respectively. From 2002-2019: 11.7%-16.9% of eligible employees filed STD claims for 82.1%-995.9% of baseline days and 80.4%-125.9% median payments; 0.6%-2.9% of eligible employees filed LTD claims for 66.6%-114.7% of baseline days and 63.2%-254.8% median payments; 0.3%-1.6% of eligible employees filed WC claims for 44.0%-472.8% of baseline days and 70.4%-271.5% median payments. Median payments were highest in 2012, 2019, 2003 for STD, LTD, WC, respectively and the most absence days were used in 2017 for SL and LTD, 2008 for STD, and 2005 WC. Conclusion: Employees with rheumatoid arthritis used absence benefits at differing rates over time with varying leave-lengths and payments. Using a constant cost or salary replacement factor for absence costs over time and across benefits is not accurate.

scholarly journals Influences on Attitudes Regarding Potential COVID-19 Vaccination in the United States

Vaccines ◽  
2020 ◽  
Vol 8 (4) ◽  
pp. 582 ◽  
Author(s):  
Kendall Pogue ◽  
Jamie L. Jensen ◽  
Carter K. Stancil ◽  
Daniel G. Ferguson ◽  
Savannah J. Hughes ◽  
...  
Keyword(s):  
United States ◽  
Structural Equation Modeling ◽  
Side Effects ◽  
Structural Equation ◽  
The United States ◽  
Equation Modeling ◽  
Vaccine Acceptance ◽  
The World ◽  
Short And Long Term

The COVID-19 pandemic continues to ravage the world, with the United States being highly affected. A vaccine provides the best hope for a permanent solution to controlling the pandemic. However, to be effective, a vaccine must be accepted and used by a large majority of the population. The aim of this study was to understand the attitudes towards and obstacles facing vaccination with a potential COVID-19 vaccine. To measure these attitudes a survey was administered to 316 respondents across the United States by a survey corporation. Structural equation modeling was used to analyze the relationships of several factors with attitudes toward potential COVID-19 vaccination. Prior vaccine usage and attitudes predicted attitudes towards COVID-19 vaccination. Assessment of the severity of COVID-19 for the United States was also predictive. Approximately 68% of all respondents were supportive of being vaccinated for COVID-19, but side effects, efficacy and length of testing remained concerns. Longer testing, increased efficacy and development in the United States were significantly associated with increased vaccine acceptance. Messages promoting COVID-19 vaccination should seek to alleviate the concerns of those who are already vaccine-hesitant. Messaging directed at the benefits of vaccination for the United States as a country would address the second predictive factor. Enough time should be taken to allay concerns about both short- and long-term side effects before a vaccine is released.

scholarly journals Short- and long-term associations between widowhood and mortality in the United States: longitudinal analyses

2013 ◽  
Vol 36 (3) ◽  
pp. 382-389 ◽  
Author(s):  
J. Robin Moon ◽  
M. Maria Glymour ◽  
Anusha M. Vable ◽  
Sze Y. Liu ◽  
S. V. Subramanian
Keyword(s):  
United States ◽  
The United States ◽  
Longitudinal Analyses ◽  
Short And Long Term

scholarly journals Influences on Attitudes regarding Potential COVID-19 Vaccination in the United States

2020 ◽  
Author(s):  
Kendall Pogue ◽  
Jamie Jensen ◽  
Carter Stancil ◽  
Daniel Ferguson ◽  
Savannah Hughes ◽  
...  
Keyword(s):  
United States ◽  
Side Effects ◽  
Predictive Factor ◽  
Structural Equation ◽  
The United States ◽  
Vaccine Acceptance ◽  
Equation Modelling ◽  
The World ◽  
Short And Long Term

The COVID-19 pandemic continues to ravage the world, with the United States being highly affected. A vaccine provides the best hope for a permanent solution to controlling the pandemic. However, to be effective, a vaccine must be accepted and used by a large majority of the population. Structural equation modelling was used to analyze the relationships of several factors with attitudes toward potential COVID-19 vaccination. The survey was administered to 316 respondents across the United States by a survey corporation. Prior vaccine usage and attitudes predicted attitudes towards COVID-19 vaccination. Assessment of the severity of COVID-19 for the United States was also predictive. Approximately 68% of all respondents were supportive of being vaccinated for COVID-19, but side effects, efficacy, and length of testing remained concerns. Longer testing, increased efficacy and development in the United States were significantly associated with increased vaccine acceptance. Messages promoting COVID-19 vaccination should seek to alleviate the concerns of those who are already vaccine-hesitant. Messaging directed at the benefits of vaccination for the United States as a country would address the second predictive factor. Enough time should be taken to allay concerns about both short and long-term side effects before a vaccine is released.

Ensuring High-Quality Implementation and Sustainability of Evidence-Based Interventions and Coalitions

2018 ◽  
Author(s):  
Abigail A. Fagan ◽  
J. David Hawkins ◽  
Richard F. Catalano ◽  
David P. Farrington
Keyword(s):  
United States ◽  
The United States ◽  
Technical Support ◽  
Evidence Based ◽  
Community Based ◽  
High Quality ◽  
Core Components ◽  
Over Time ◽  
Coalition Functioning

This chapter reviews the importance of delivering community-based systems and EBIs with fidelity (i.e., in accordance with their implementation requirements) and sustaining these interventions over time. The chapter describes the training and technical support provided in CTC to ensure that coalitions take necessary actions to maintain their functioning in the long term and deliver EBIs in adherence to their core components and to their intended recipients. It is especially important that coalitions collect data on coalition functioning and EBI delivery and use these data when problems are identified. Examples of how CTC coalitions in the United States and other countries have engaged in these efforts are highlighted.

The Short- and Long-Term Burden of Acute Pancreatitis in the United States

Pancreas ◽  
2021 ◽  
Vol 50 (3) ◽  
pp. 330-340
Author(s):  
Shibani Pokras ◽  
Markqayne Ray ◽  
Shan Zheng ◽  
Yao Ding ◽  
Chi-Chang Chen
Keyword(s):  
United States ◽  
Acute Pancreatitis ◽  
The United States ◽  
Short And Long Term
Sign in / Sign up

Export Citation Format

Share Document